论文信息 - Phase 3, multicentre, double-blind, randomised, parallel-group, placebo-controlled study of camostat mesilate (FOY-305) for the treatment of COVID-19 (CANDLE study) - 字舞流文

Phase 3, multicentre, double-blind, randomised, parallel-group, placebo-controlled study of camostat mesilate (FOY-305) for the treatment of COVID-19 (CANDLE study)

H. Kakeya | K. Tsushima | N. Uemura | K. Yoshida | Y. Kichikawa | J. Kadota | N. Komura | M. Shinoda | Y. Kido | T. Kinoshita | Y. Nisizaki | K. Shiraki | Y. Hirai | M. Sinkai